Entries by IDEAL

Damian Brzyski earns distinguished paper award

The Eastern North American Region (ENAR) of the International Biometric Society awarded Damian Brzyski with the Distinguished Student Paper Award for his work on group SLOPE which he performed within the IDeAl project. Brzyski’s paper, entitled “Group SLOPE as Method for SNPs Selection with the False Discovery Rate Control,” is focused on a new method […]

This week: Joint Meeting at EMA

The final stages of the projects IDeAl, InSPiRe and asterix conclude with the joint workshop Seventh Framework Programme (FP7) small-population research methods projects and regulatory application hosted by the European Medicines Agency in London. During the workshop, the three projects will have the opportunity to intertwine their research in various in-depth workshops, unify their great […]

Malta 2017: MMA-EURORDIS-COMP-IMI Conference

Ralf-Dieter Hilgers is representing IDeAl, and disseminating the IDeAl results at the MMA-EURORDIS-COMP-IMI Conference in Malta this week. As an invited speaker, he seized the chance to present “Innovative statistical design methodologies for clinical trials in small populations focussing on rare diseases“.  This conference, organized during the Maltese Presidency aims at discussing the development of […]

Joint Dissemination Workshop at EMA

Three projects, Asterix, IDeAl and InSPiRe, have been funded by the EU within the Seventh Framework Programme to develop new methodology on design and analysis of small population clinical trials since 2013. A joint dissemination workshop will be held at the European Medicines Agency on 29 & 30 March 2017. The aim of the workshop […]

Rare Disease Day 2017

Under the slogan “With research, possibilities are limitless”, todays Rare Disease Day 2017 is focussusing on the theme research. As the Orphanet Journal of Rare Diseases states it, continual research is necessary in order to unlock the mysteries often presented by rare diseases. The IDeAl consortium is proud to support this process with the latest […]